Target intelligence / Profile preview

Vascular lumen occlusion

Molecular classification
Other (not receptor, enzyme, transporter, etc.; it's a biological event or anatomical state)
01

Overview

Vascular lumen occlusion refers to the blockage of a blood vessel’s lumen, impeding blood flow. It can result from internal factors (such as clots, plaque, foreign material) or external compression. This process is central to diseases such as stroke (cerebrovascular occlusion), retinal artery/vein occlusion, myocardial infarction, and peripheral artery disease, and can cause tissue ischemia, necrosis, or infarction. It is sometimes induced intentionally in medical procedures (e.g., embolisation or vessel coiling) to control bleeding or reduce blood supply to tumors. Vascular lumen occlusion is not a specific molecular target like a receptor or enzyme; it is an anatomical and pathological state or process. Structured drug discovery databases and mechanistic biology resources do not treat it as a canonical molecule or gene target. If you seek an actual molecular target involved in vascular occlusion (such as coagulation factors, platelet receptors, or endothelial adhesion molecules), those should be specified separately.

Other names
Vascular occlusionvessel occlusionarterial occlusionvenous occlusionretinal artery occlusioncerebrovascular occlusion
02

Mechanism of action

For therapeutic intervention: Dissolution of clot (thrombolysis), inhibition of further coagulation (anticoagulation), mechanical blockage (embolisation/coiling)

03

Biological functions

Other (blockage of blood flow; not a function, but a pathological process)
04

Disease associations

Cardiovascular disease (e.g., stroke, myocardial infarction, peripheral artery disease)Ocular diseases (e.g., retinal artery or vein occlusion)Ischemia/Necrosis (tissue injury from loss of blood supply)
05

Safety considerations

Ischemia and tissue necrosisRisk of stroke, myocardial infarction, blindness, or tissue death depending on vessel locationComplications from therapeutic occlusion (e.g., hemorrhage, inadequate collateral circulation)
06

Interacting drugs

Thrombolytics (e.g., tissue plasminogen activator for blood clot dissolution)

3 more in the full profile.

07

Biomarkers

D-dimer (marker of clot formation/lysis)Imaging findings (Doppler sonography, cerebral angiogram, retinal angiography)

Beyond the preview

Go deeper on Vascular lumen occlusion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular lumen occlusion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call